What is BioElectronics?
Founded in 2000 and headquartered in Frederick, Maryland, BioElectronics is dedicated to the manufacturing and retailing of electro-medical devices. The company focuses on providing innovative alternatives for pain management, positioning itself within the competitive medical technology landscape. Its product offerings aim to address unmet needs in patient care, leveraging technology to improve therapeutic outcomes. The company's longevity suggests a sustained effort in product development and market penetration within the healthcare industry.
How much funding has BioElectronics raised?
BioElectronics has raised a total of $112K across 1 funding round:
Debt
$112K
Debt (2021): $112K with participation from PPP
Key Investors in BioElectronics
PPP
Public-Private Partnership
What's next for BioElectronics?
The recent large-scale, late-stage funding, characterized as a major strategic investment, signals BioElectronics' readiness for significant expansion and market consolidation. This infusion of capital is likely to accelerate product development, enhance manufacturing capabilities, and broaden distribution channels. The company is poised to further solidify its market presence and potentially explore new therapeutic areas or technological advancements in electro-medical solutions. This strategic financing is a critical step in its growth trajectory, enabling it to compete more effectively and drive innovation in pain management.
See full BioElectronics company page
